Lynch syndrome (LS) is the most common hereditary cancer syndrome, for which the oncogenicity results from heterozygous germline pathogenic variants in genes involved in the mismatch repair (MMR) mechanism, including MLH1, MSH2, MSH6, and PMS2 [1]. Here, MLH1 is linked to Lynch syndrome.